Point72 (DIFC)’s DexCom DXCM Stock Holding History

Point72 (DIFC)’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$21M	Buy	312,430 +147,230	+89%	+$11.7M	1.38%	14
2025 Q2	$14.4M	Buy	165,200 +46,732	+39%	+$3.66M	0.55%	30
2025 Q1	$8.09M	Buy	+118,468	New	+$9.67M	0.33%	71

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Point72 (DIFC)'s DXCM Position: Q3 2025 in Review

Point72 (DIFC) increased its DexCom (DXCM) stake by 89% in Q3 2025, buying an estimated $11.7M and bringing the position to 312,430 shares worth $21M. The position accounts for 1.38% of the portfolio, ranked #14.

Point72 (DIFC) first reported a position in DXCM in Q1 2025 and has held it in 3 quarters since. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

Point72 (DIFC) held 312,430 shares of DexCom worth $21M as of Q3 2025.
Point72 (DIFC) bought 147,230 DexCom shares in Q3 2025, an estimated $11.7M.
DexCom made up 1.38% of Point72 (DIFC)'s portfolio in Q3 2025, its #14 holding.
Point72 (DIFC) first reported a position in DexCom in Q1 2025 and has held it in 3 quarters since.
911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.